New painkiller GRT7041 enters first human safety tests
NCT ID NCT07289776
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This early-stage study tests a new drug called GRT7041 in 70 healthy volunteers to see if it is safe and how the body processes it. The trial has two parts: some participants get a single dose, others get multiple doses over up to 14 days. The goal is to find the right dose and check for side effects before testing in people with pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT OF PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGChristchurch, 8011, New Zealand
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.